JUL 22, 2021 9:00 AM PDT

Enhancing Myelin to Treat Alzheimer's Disease

WRITTEN BY: J. Bryce Ortiz

Brain cells, or neurons, communicate through electrochemical signals. The electrical signals travel down a neuron’s long axon to reach neurons in other areas of the brain in which it intends to communicate. A specialized type of brain cell called an oligodendrocyte produces myelin, a fatty protein that encases and insulates neuronal axons which allows electrical signals to propagate and travel efficiently to its target. In individuals with Alzheimer’s disease, myelin and oligodendrocytes are significantly altered which may contribute to the cognitive decline seen in the disease. That is, damaged or disrupted oligodendrocytes can lead to less myelin which impairs neuronal communication and cognition. In a recent study published in the journal Neuron, researchers investigated whether enhancing myelin can help prevent cognitive decline in a mouse model of Alzheimer’s disease.

Alzheimer’s disease affects up to 24 million people world-wide and is the leading cause of progressive dementia in older adults which leads to loss of memory and other important mental functions. While there is currently no cure for Alzheimer’s disease, there are major pushes in research and pharmaceutical development to lessen the harmful effects of Alzheimer’s and halt the progression of the disease. 

In the current study, the researchers first investigated whether myelin loss occurred in Alzheimer’s disease patients. To do this, they quantified myelin in the brains of deceased individuals who were diagnosed with Alzheimer’s and compared them to the brains of age-matched individuals without the disease. They found that there was a significant decrease of myelin in brain areas important for cognition. 

To study this further, the researchers then utilized a well-characterized mouse model of Alzheimer’s disease. They found that in this model, there was an accelerated degeneration of myelin in the mouse brains and that myelin loss was accompanied by poor performance on memory related cognitive tasks. The researchers then questioned whether rescuing myelin by administration of a drug that promotes myeline regeneration would improve cognition and increase myelin. They found that enhancing myelin renewal was associated with improved performance on the cognitive tasks. These findings provide insight into a relatively unexplored pharmaceutical target in Alzheimer’s disease and show that increasing myelin may help prevent cognitive decline. 

 

Sources: CellAlzheimer’s Association

About the Author
  • Science and medical writer | Researcher | Interested in the intersection between translational science, drug development, and policy
You May Also Like
JUN 28, 2021
Drug Discovery & Development
Could Deep Brain Stimulation Treat Schizophrenia?
JUN 28, 2021
Could Deep Brain Stimulation Treat Schizophrenia?
From a new case study, researchers from Johns Hopkins University have found that deep brain stimulation may be able to i ...
JUN 29, 2021
Technology
Can Digital Simulations Replace Real People in Clinical Trials? Maybe
JUN 29, 2021
Can Digital Simulations Replace Real People in Clinical Trials? Maybe
Clinical trials are essential to the development of new drugs and medicines, and they offer new insights every day about ...
JUL 05, 2021
Neuroscience
People with Autism More Likely to Self-Medicate with Recreational Drugs
JUL 05, 2021
People with Autism More Likely to Self-Medicate with Recreational Drugs
Researchers from the University of Cambridge have found that people with autism are more likely than people without the ...
JUL 12, 2021
Cannabis Sciences
How does CBD Affect Heart Arrhythmia?
JUL 12, 2021
How does CBD Affect Heart Arrhythmia?
Heart arrhythmias happen when the heart beats too fast, too slow, or irregularly. According to the Centers for Dise ...
AUG 11, 2021
Neuroscience
Beige Fat Cells Protect the Brain from Dementia
AUG 11, 2021
Beige Fat Cells Protect the Brain from Dementia
‘Beige’ fat reduces inflammation in mouse brains, and may provide protection from dementia. The correspondin ...
SEP 07, 2021
Health & Medicine
Vaccines- a Long History of Cost-Benefit Analysis
SEP 07, 2021
Vaccines- a Long History of Cost-Benefit Analysis
Vaccination and new treatments for diseases have remained topics of skepticism since their inception. When it came to an ...
Loading Comments...